Michael Okunewitch Analyst PerformanceSenior Analyst, Biotechnology at Maxim GroupMichael Okunewitch is a stock analyst at Maxim Group focused in the medical sector, covering 14 publicly traded companies. Over the past year, Michael Okunewitch has issued 10 stock ratings, including buy and hold recommendations. While full access to Michael Okunewitch's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Okunewitch's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings18 Last 4 YearsBuy Recommendations77.78% 14 Buy RatingsCompanies Covered14 Unique Companies Ratings Distribution18RatingsDistribution of strong buy, buy, hold, and sell ratings by Michael Okunewitch.RatingPercentageCount Strong Buy0.0%0 ratings Buy77.8%14 ratings Hold22.2%4 ratings Sell0.0%0 ratingsOut of 18 total stock ratings issued by Michael Okunewitch at Maxim Group, the majority (77.8%) have been Buy recommendations, followed by 22.2% Hold.Best & Worst CallsBest Call0000.0%LCTXJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%MYNZFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ78.6% of companies on NASDAQ11 companiesNYSEAMERICAN14.3% of companies on NYSEAMERICAN2 companiesOTCMKTS7.1% of companies on OTCMKTS1 companyMichael Okunewitch, an analyst at Maxim Group, currently covers 14 companies listed on NASDAQ, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical13 companies92.9%Services1 company7.1%Michael Okunewitch of Maxim Group specializes in stock coverage within the Medical sector, with additional focus on Services companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE11 companies78.6%SERVICES – RESEARCH, DEVELOPMENT, TESTING LABS1 company7.1%MEDICAL CARE FACILITIES1 company7.1%MED - DRUGS1 company7.1% Michael Okunewitch's Ratings History at Maxim Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAIDX20/20 Biolabs5/11/2026Initiated Coverage$1.37$5.00Buy$0.0000.00% ROILGVNLongeveron5/11/2026Downgrade$0.85Hold$0.0000.00% ROIAIDX20/20 Biolabs5/11/2026Initiated Coverage$1.37$5.00Buy$0.0000.00% ROIFBLGFibroBiologics5/4/2026Downgrade$1.46Hold$0.0000.00% ROIVNRXVolitionRX12/3/2025Downgrade$0.28Hold$0.0000.00% ROIRANIRani Therapeutics10/20/2025Boost Price Target$2.65$10.00Buy$0.0000.00% ROICTORCitius Oncology9/23/2025Upgrade$1.78$6.00Buy$0.0000.00% ROIANEBAnebulo Pharmaceuticals7/23/2025Downgrade$3.33Hold$0.0000.00% ROIHCWBHCW Biologics5/29/2025Lower Price Target$8.05$35.00Buy$0.0000.00% ROIANEBAnebulo Pharmaceuticals5/15/2025Lower Price Target$1.04$3.00Buy$0.0000.00% ROIRADXRadiopharm Theranostics5/1/2025Initiated Coverage$3.91$12.00Buy$0.0000.00% ROICMMBChemomab Therapeutics2/20/2025Boost Price Target$6.98$28.00Buy$0.0000.00% ROIMYNZMainz Biomed2/14/2025Initiated Coverage$6.53$14.00Buy$0.0000.00% ROILCTXLineage Cell Therapeutics1/10/2025Lower Price Target$0.53$3.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
